lactobionic acid has been researched along with Liver Neoplasms in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 15 (83.33) | 24.3611 |
| 2020's | 3 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Du, K; Hu, H; Tao, Y; Xiao, W; Xu, D; Xu, Q; Yuan, X | 1 |
| Coelho, JFJ; Faneca, H; Mendonça, PV; Santo, D; Serra, AC | 1 |
| Du, J; Hou, Z; Liu, X; Tang, R; Wang, L; Wang, X; Xie, Z | 1 |
| He, L; Tang, R; Wang, J; Wang, X; Wei, B; Yan, GQ | 1 |
| Altamura, E; Azzariti, A; Cutrignelli, A; Denora, N; Di Fonte, R; Franco, M; Iacobazzi, RM; Laquintana, V; Lopalco, A; Lopedota, AA; Porcelli, L | 1 |
| Fan, L; Jiang, K; Li, T; Shao, J; Zhao, R; Zheng, G | 1 |
| Anwar, DM; Bekhit, AA; Elkhodairy, KA; Elzoghby, AO; Helmy, MW; Kamal, MK; Khattab, SN | 1 |
| Alonso, S | 1 |
| Gao, X; Ji, Y; Jian, X; Li, Z; Liu, Z; Ni, W; Sun, S; Wu, L | 1 |
| Han, B; Liu, C; Zhang, H; Zhang, Q | 1 |
| Karmakar, P; Pal, K; Sahu, SK; Samui, A | 1 |
| Abdelmoneem, MA; Abdulkader, MA; Elkhodairy, KA; Elnaggar, MA; Elzoghby, AO; Fang, JY; Hammady, RS; Helmy, MW; Kamel, SM; Zaky, A | 1 |
| Fu, F; Shen, M; Shi, X; Wen, S; Wu, Y; Zhu, J | 1 |
| Lin, C; Ni, JS; Wang, C; Wang, ZG; Wu, MC; Yang, Y; Yuan, SX; Zhao, LH; Zhou, WP | 1 |
| Cheng, X; Fu, S; Hu, L; Tang, R; Wang, J; Wang, X; Yan, G; Yang, G; Zhang, P | 1 |
| Hassanzadeh, F; Khadem, M; Sadeghi, H; Varshosaz, J | 1 |
| Ai-jun, Z; Di-jia, Y; Jing-yu, X; Kong-lang, X; Lin-sen, S; Min, G; Qiang, Z; Qiao-ling, Z; Wei-liang, C; Xiao-feng, Z; Xue-nong, Z; Yang, L; Yi, Z; Ying, W; Zong-lin, G | 1 |
| Han, Y; Li, C; Li, Y; Yu, P; Zhang, X | 1 |
1 review(s) available for lactobionic acid and Liver Neoplasms
| Article | Year |
|---|---|
Exploiting the bioengineering versatility of lactobionic acid in targeted nanosystems and biomaterials.
Topics: Animals; Antineoplastic Agents; Biocompatible Materials; Disaccharides; Drug Carriers; Drug Delivery Systems; Gene Transfer Techniques; Humans; Liver; Liver Neoplasms; Nucleic Acids; Tissue Engineering; Tissue Scaffolds | 2018 |
17 other study(ies) available for lactobionic acid and Liver Neoplasms
| Article | Year |
|---|---|
Conjugates of lactobionic acid and IR820: New photosensitizers for efficient photodynamic therapy of hepatoma cells.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Indocyanine Green; Ligands; Liver Neoplasms; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species | 2022 |
Targeted downregulation of MYC mediated by a highly efficient lactobionic acid-based glycoplex to enhance chemosensitivity in human hepatocellular carcinoma cells.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; RNA, Small Interfering; Sorafenib | 2023 |
Lactobionic acid-modified phycocyanin nanoparticles loaded with doxorubicin for synergistic chemo-photodynamic therapy.
Topics: Antibiotics, Antineoplastic; Cell Survival; Disaccharides; Doxorubicin; Drug Compounding; Drug Liberation; Drug Stability; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Liver Neoplasms; Nanoparticles; Nanotechnology; Photochemotherapy; Photosensitizing Agents; Phycocyanin; Reactive Oxygen Species; Spheroids, Cellular; Time Factors | 2021 |
Bromelain-decorated hybrid nanoparticles based on lactobionic acid-conjugated chitosan for in vitro anti-tumor study.
Topics: Antibiotics, Antineoplastic; Bromelains; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Chitosan; Disaccharides; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Humans; Liver Neoplasms; Nanoparticles; Neoplasms | 2017 |
Targeting human liver cancer cells with lactobionic acid-G(4)-PAMAM-FITC sorafenib loaded dendrimers.
Topics: Asialoglycoprotein Receptor; Dendrimers; Disaccharides; Drug Carriers; Fluorescein-5-isothiocyanate; Hep G2 Cells; Humans; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Sorafenib | 2017 |
Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplex.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Chitosan; Delayed-Action Preparations; Disaccharides; Drug Synergism; Humans; Hydrogen-Ion Concentration; Liver Neoplasms; Lung Neoplasms; Male; Mice; Nanoparticles; Niacinamide; Phenylurea Compounds; Porosity; Rats; Silicon Dioxide; Sorafenib; Triterpenes; Ursolic Acid | 2017 |
Lactobionic/Folate Dual-Targeted Amphiphilic Maltodextrin-Based Micelles for Targeted Codelivery of Sulfasalazine and Resveratrol to Hepatocellular Carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Disaccharides; Drug Delivery Systems; Folic Acid; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Micelles; Polysaccharides; Resveratrol; Sulfasalazine; Xenograft Model Antitumor Assays | 2018 |
Dual-Targeting Nanoparticles: Codelivery of Curcumin and 5-Fluorouracil for Synergistic Treatment of Hepatocarcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biotin; Carcinoma, Hepatocellular; Curcumin; Disaccharides; Drug Carriers; Drug Liberation; Drug Synergism; Fluorouracil; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Nanoparticles; Polyethylene Glycols; Polyglactin 910; Tissue Distribution; Xenograft Model Antitumor Assays | 2019 |
Preparation of a one-dimensional nanorod/metal organic framework Janus nanoplatform via side-specific growth for synergistic cancer therapy.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Disaccharides; Drug Screening Assays, Antitumor; Gold; Hep G2 Cells; Humans; Infrared Rays; Liver Neoplasms; Liver Neoplasms, Experimental; MCF-7 Cells; Metal-Organic Frameworks; Mice; Mice, Inbred BALB C; Nanostructures; Photosensitizing Agents; Phototherapy; Tomography, X-Ray Computed; Tumor Cells, Cultured | 2019 |
In situ synthesized lactobionic acid conjugated NMOFs, a smart material for imaging and targeted drug delivery in hepatocellular carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Disaccharides; Doxorubicin; Drug Carriers; Drug Delivery Systems; Humans; Liver Neoplasms; Metal-Organic Frameworks | 2019 |
Dual-Targeted Lactoferrin Shell-Oily Core Nanocapsules for Synergistic Targeted/Herbal Therapy of Hepatocellular Carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Diethylnitrosamine; Disaccharides; Drug Delivery Systems; Gene Expression Regulation, Neoplastic; Glycyrrhetinic Acid; Hep G2 Cells; Humans; Ki-67 Antigen; Lactoferrin; Liver Neoplasms; Mice; Nanocapsules; NF-kappa B; Phytotherapy | 2019 |
Multifunctional lactobionic acid-modified dendrimers for targeted drug delivery to liver cancer cells: investigating the role played by PEG spacer.
Topics: Antineoplastic Agents; Cell Survival; Dendrimers; Disaccharides; Doxorubicin; Drug Carriers; Hep G2 Cells; Humans; Liver Neoplasms; Polyethylene Glycols | 2014 |
Ligand-directed stearic acid grafted chitosan micelles to increase therapeutic efficacy in hepatic cancer.
Topics: Animals; Apoptosis; Cell Line, Tumor; Chitosan; Disaccharides; Doxorubicin; Drug Carriers; Drug Delivery Systems; Hep G2 Cells; Humans; Liver Neoplasms; Mice, Nude; Micelles; Polymers; Stearic Acids; Xenograft Model Antitumor Assays | 2015 |
Stepwise targeted drug delivery to liver cancer cells for enhanced therapeutic efficacy by galactose-grafted, ultra-pH-sensitive micelles.
Topics: Animals; Cell Death; Cell Line, Tumor; Cell Proliferation; Disaccharides; Doxorubicin; Drug Delivery Systems; Drug Liberation; Dynamic Light Scattering; Galactose; Humans; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Liver Neoplasms; Mice; Micelles; Particle Size; Polymers; Proton Magnetic Resonance Spectroscopy; Tissue Distribution; Treatment Outcome | 2017 |
Galactosylated nanostructured lipid carriers for delivery of 5-FU to hepatocellular carcinoma.
Topics: Acetone; Amines; Antineoplastic Agents; Asialoglycoprotein Receptor; Carcinoma, Hepatocellular; Delayed-Action Preparations; Disaccharides; Drug Carriers; Drug Delivery Systems; Flow Cytometry; Fluorouracil; Galactose; Glycerides; Hep G2 Cells; Humans; Liver Neoplasms; Magnetic Resonance Spectroscopy; Nanoparticles; Oleic Acid; Particle Size; Polysorbates; Spectroscopy, Fourier Transform Infrared; Surface Properties; Tetrazolium Salts; Thiazoles; Toxicity Tests | 2012 |
Hepatocyte-targeted delivery using ph-sensitive liposomes loaded with lactosylnorcantharidin phospholipid complex: preparation, characterization, and therapeutic evaluation in vivo and in vitro.
Topics: Animals; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Disaccharides; Drug Delivery Systems; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liposomes; Liver; Liver Neoplasms; Male; Mice; Phospholipids | 2012 |
Hydrotropic polymeric mixed micelles based on functional hyperbranched polyglycerol copolymers as hepatoma-targeting drug delivery system.
Topics: Antineoplastic Agents, Phytogenic; Asialoglycoprotein Receptor; beta-Cyclodextrins; Binding, Competitive; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Chemistry, Pharmaceutical; Delayed-Action Preparations; Disaccharides; Dose-Response Relationship, Drug; Drug Carriers; Drug Stability; Endocytosis; Feasibility Studies; Glycerol; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Liver Neoplasms; Micelles; Microscopy, Confocal; Molecular Structure; Nanoparticles; Paclitaxel; Polymers; Solubility; Technology, Pharmaceutical; Time Factors | 2013 |